Personalizing Diabetes Management in Liver Transplant Recipients: The New Era for Optimizing Risk Management
Brooks Richardson, Mohammad Qasim Khan, Sara A Brown, Kymberly D Watt, Manhal Izzy – 16 December 2021 – Post‐transplant diabetes mellitus (PTDM) is a significant contributor to morbidity and mortality in liver transplant recipients (LTRs). With concurrent comorbidities and use of various immunosuppression medications, identifying a safe and personalized regimen for management of PTDM is needed. There are many comorbidities associated with the post‐transplant course including chronic kidney disease, cardiovascular disease, allograft steatosis, obesity, and de novo malignancy.